These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2185771)

  • 21. [Drug therapy of hypercholesterolemia].
    Schwandt P; Richter WO
    Wien Klin Wochenschr; 1995; 107(18):544-8. PubMed ID: 7483641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simvastatin in the treatment of hypercholesterolemia in elderly patients.
    Antonicelli R; Onorato G; Pagelli P; Pierazzoli L; Paciaroni E
    Clin Ther; 1990; 12(2):165-71. PubMed ID: 2354486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long term treatment of moderate to severe hypercholesterolemia with low dose statin. Comparison of simvastatin and pravastatin].
    Spagnolli W; Ramponi C; Focher C; Dal Piaz A; Torboli P; Miori R; De Venuto G
    Recenti Prog Med; 1996 Nov; 87(11):538-42. PubMed ID: 9122535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term prevention of premature coronary atherosclerosis in homozygous familial hypercholesterolemia.
    Jaeger BR; Tsobanelis T; Bengel F; Schwaiger M; Seidel D
    J Pediatr; 2002 Jul; 141(1):125-8. PubMed ID: 12091863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
    Geiss HC; Otto C; Parhofer KG
    Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
    Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
    Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of clinical trials comparing HMG-CoA reductase inhibitors.
    Illingworth DR; Tobert JA
    Clin Ther; 1994; 16(3):366-85; discussion 365. PubMed ID: 7923304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug].
    Mol MJ; Stuyt PM; Stalenhoef AF
    Ned Tijdschr Geneeskd; 1989 Feb; 133(7):362-6. PubMed ID: 2927555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A population-based treat-to-target pharmacoeconomic analysis of HMG-CoA reductase inhibitors in hypercholesterolemia.
    Hilleman DE; Phillips JO; Mohiuddin SM; Ryschon KL; Pedersen CA
    Clin Ther; 1999 Mar; 21(3):536-62. PubMed ID: 10321422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hypercholesterolemia and prevention of coronary artery disease after heart transplantation by combination of low-dose simvastatin and HELP-LDL-apheresis.
    Wenke K; Thiery J; Arndtz N; Meiser BM; Seidel D; Reichart B
    Transplant Proc; 1992 Dec; 24(6):2674-6. PubMed ID: 1465897
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease.
    Kroon AA; van Asten WN; Stalenhoef AF
    Ann Intern Med; 1996 Dec; 125(12):945-54. PubMed ID: 8967704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS).
    Aengevaeren WR; Kroon AA; Stalenhoef AF; Uijen GJ; van der Werf T
    J Am Coll Cardiol; 1996 Dec; 28(7):1696-704. PubMed ID: 8962554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia.
    Illingworth DR; Bacon S
    Am J Cardiol; 1987 Oct; 60(12):33G-42G. PubMed ID: 3314447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New strategies in treatment of severe hypercholesterolemia in coronary patients: HMG-CoA reductase inhibitors and H.E.L.P.-LDL apheresis].
    Thiery J; Seidel D
    Versicherungsmedizin; 1992 Dec; 44(6):186-92. PubMed ID: 1475888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia.
    Todd PA; Goa KL
    Drugs; 1990 Oct; 40(4):583-607. PubMed ID: 2083515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3-Hydroxy-3-methylglutaryl--coenzyme A reductase inhibitors in the treatment of hypercholesterolemia.
    Hoeg JM; Brewer HB
    JAMA; 1987 Dec; 258(24):3532-6. PubMed ID: 3316727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Addressing the spectrum of hypercholesterolemia.
    Grundy SM; Mazzaferri EL
    Hosp Pract (1995); 1996 Jun; 31(6):43-8, 53-5, 59; discussion 60. PubMed ID: 8675545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term clinical experience with HELP-LDL-apheresis in combination with HMG-CoA-reductase inhibitors for maximum treatment of coronary heart disease associated with severe hypercholesterolemia.
    Eisenhauer T; Armstrong VW; Schuff-Werner P; Schütz E; Thiery J; Scheler F; Seidel D
    ASAIO Trans; 1989; 35(3):580-3. PubMed ID: 2597539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of therapy with diet and simvastatin on atherosclerosis in hypercholesterolemic patients.
    Barlow CW; Friedman BM; Myburgh DP; Soicher ER; Steenkamp WF; Smith DH
    Cardiovasc Drugs Ther; 1990 Oct; 4(5):1389-94. PubMed ID: 2278874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lovastatin and simvastatin prevention studies.
    Jones PH
    Am J Cardiol; 1990 Sep; 66(8):39B-43B. PubMed ID: 2206035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.